Clinical benefit of cholesterol lowering treatments: Meta-analysis of randomized therapeutic trials;Benefices cliniques des traitements hypocholesterolemiants: Meta-analyse des essais therapeutiques randomises

Presse Medicale

Volumn 29, Issue 17, 2000, Pages 965-976

  Cucherat, M ^a   Lievre M ^a   Gueyffier, F ^a  

^a UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CLOFIBRATE; FIBRIC ACID DERIVATIVE; GEMFIBROZIL; NICOTINIC ACID; RESIN; STATIN; HYPOCHOLESTEROLEMIC AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; LOW CALORY DIET; MALE; META ANALYSIS; MORTALITY; RISK BENEFIT ANALYSIS; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FRANCE; HEART INFARCTION; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANTICHOLESTEREMIC AGENTS; FRANCE; HUMANS; HYPERCHOLESTEROLEMIA; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034643572     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Downs JR, Clearfield M, Weis S et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. Results of AFCAPS/TexCAPS JAMA 1998 ; 279:1615-22.
2. The Long Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Croup, Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998 ; 339:1349-57.
3. Rubins HB, Robins SJ, Collins D et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of nigh-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999 ; 341:410-8.
4. Oliver MF. Doubts about preventing coronary heart disease. BMJ 1992 ; 304:303-4.
5. Frantz ID, Dawson EA, Ashman PL. Test of effect of lipid lowering by diet on cardiovascular risk. The Minnesotta Coronary Survey. Arteriosclerosis 1989 ; 9:129-35.
6. Frantz ID, Dawson EA, Kuba K, Brewer ER. The Minnesota Coronary Survey: effect of diet on cardiovascular events and deaths (abstract) Circulation 1975 ; 51(supp 2):4.
7. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339:1523-6.
8. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatm in men with hypercholesterolemia. N Engl J Med 1995; 333:1301-7.
9. Manninen V, Elo O, Frick MM. Lipid alteration and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA 1988 ; 260:641-51.
10. WHO. Prevention of coronary heart disease. Technical Report Series 678 1982.
11. Anonymous. WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Lancet 1984; ii:600-4.
12. Lipid Research Clinics Program. The lipid research clinics coronary primary prevention trial results. I. Reduction in incidence of coronary heart disease. JAMA 1984 ; 251:351-64.
13. Carlson L, Danielson M, Exberg I. Reduction of myocardial reinfarction by the combined treatment with clofibrate and nicotinic acid. Arterioscleiosis 1977 ; 28:81-6.
14. Dayton S, Pearce ML, Hashimoto S. A controlled clinical trial of a diet in high unsatured fat in preventing complicaton of the atherosclerosis. Circulation 1969 ; 40(supp 2):1-55.
15. Sacks FM, Pfeffer MA, Move LA et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335:1001-9.
16. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994 ; 344:1383-9.
17. The Coronary Drug Project Research Group. Clofibrate and niacin in coronary heart disease. JAMA 1975 ; 231:360-81.
18. Anonymous. Trial of dofibrate in the treatment of ischaemic heart disease. Five year study by a group of physicians of the Newcastle upon Tyne region. BMJ 1971 ; 4:767-75.
19. Report by a Research Committee of the Scottish Society of Physicians. Ischemic heart disease : a secondary prevention trial using clofibrate. BMJ 1971 ; 4:775-84.
20. Woodhill JM, Palmer AJ, Leelarthaepin B, Mc Gilchrist C, Blacket RB. Low fat, low cholesterol diet in secondary prevention of coronary heart disease Adv Exper Med Biol 1978; 109:317-30.
21. Report of a research Committee of the Medical Research Council. Controlled trial of soya bean oil in myocardial infarction. Lancet 1968; 2:693-9.
22. Leren P. The Oslo Diet Heart Study. Eleven year report. Circulation 1979; 42:935-42.
23. Rose GA, Thomson WB, Williams RT. Corn oil in treatment of ischaemic heart disease. BMJ 1965 ; 1:1531-3.
24. A research committee. Low-fat diet in myocardial infarction. A controlled trial Lancet 1965 ; 2:501-4.